Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Oncogene
|
May 30, 2025
LOXL2 reduces susceptibility to PARP inhibitors by promoting super-enhancer-regulated DNA damage repair in high-grade serous ovarian cancer
Chunyan Song, Yaying Lin, Chujun Cai, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 26, 2022
Highly Linear and Symmetric Synaptic Memtransistors Based on Polarization Switching in Two-Dimensional Ferroelectric Semiconductors
Yitong Chen, Dingwei Li, Huihui Ren, et al.
Oncogene
|
May 9, 2021
C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer
Jiahong Tan, Xu Zheng, Mengchen Li, et al.
Cancers
|
October 27, 2022
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis
Sandra M Swain, Harrison Macharia, Javier Cortes, et al.
The New England Journal of Medicine
|
June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast Cancer
Komal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
BMJ Open
|
May 25, 2022
Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial-a study protocol of clinical trial
Ruyuan Li, Xingyu Liu, Chunyan Song, et al.
Cancer Letters
|
August 30, 2020
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth
Lulu Hu, Dachuan Shen, Dapeng Liang, et al.
JCI Insight
|
February 11, 2021
Prolyl endopeptidase contributes to early neutrophilic inflammation in acute myocardial transplant rejection
Gregory A Payne, Nirmal S Sharma, Charitharth V Lal, et al.
Science Translational Medicine
|
May 27, 2026
Genomic instability drives POSTN<sup>+</sup> myofibroblasts via STING-WNT axis to promote immunosuppression and PARPi resistance in ovarian cancer
Dan Liu, Kangjia Tao, Chujun Cai, et al.
NPJ Breast Cancer
|
September 18, 2022
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
Sibylle Loibl, Chiun-Sheng Huang, Max S Mano, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Oncogene
|
May 30, 2025
LOXL2 reduces susceptibility to PARP inhibitors by promoting super-enhancer-regulated DNA damage repair in high-grade serous ovarian cancer
Chunyan Song, Yaying Lin, Chujun Cai, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 26, 2022
Highly Linear and Symmetric Synaptic Memtransistors Based on Polarization Switching in Two-Dimensional Ferroelectric Semiconductors
Yitong Chen, Dingwei Li, Huihui Ren, et al.
Oncogene
|
May 9, 2021
C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer
Jiahong Tan, Xu Zheng, Mengchen Li, et al.
Cancers
|
October 27, 2022
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis
Sandra M Swain, Harrison Macharia, Javier Cortes, et al.
The New England Journal of Medicine
|
June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast Cancer
Komal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
BMJ Open
|
May 25, 2022
Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial-a study protocol of clinical trial
Ruyuan Li, Xingyu Liu, Chunyan Song, et al.
Cancer Letters
|
August 30, 2020
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth
Lulu Hu, Dachuan Shen, Dapeng Liang, et al.
JCI Insight
|
February 11, 2021
Prolyl endopeptidase contributes to early neutrophilic inflammation in acute myocardial transplant rejection
Gregory A Payne, Nirmal S Sharma, Charitharth V Lal, et al.
Science Translational Medicine
|
May 27, 2026
Genomic instability drives POSTN<sup>+</sup> myofibroblasts via STING-WNT axis to promote immunosuppression and PARPi resistance in ovarian cancer
Dan Liu, Kangjia Tao, Chujun Cai, et al.
NPJ Breast Cancer
|
September 18, 2022
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
Sibylle Loibl, Chiun-Sheng Huang, Max S Mano, et al.
Page
of 11